Australia's largest stock trading and investment forum Australia's #1 stock forum

NEU

3.50%

$14.05 neuren pharmaceuticals limited

China deal?, page-22

First 22 Last

Share
Profile

Follow
arnies

761 Posts.

83

04/02/21

17:12

Post #: 50715070
Share

Originally posted by 88888acct: ↑

For example, from a previous post I did in relation to anecdotal feedback from Ph3 P3 Lilac and Lavender

"Unfortunately as required the company has tightened its enforcement of confidentiality and reporting of Ph3 results on SM (as reasonably required) However, here is an example of some of the P3 anecdotal I have collected thus far:

Parent 1:
"We really thought XXXwas on the placebo, but then week 4 she started walking down the stairs along and getting into and out of my mini van. XXX does still gain skills normally so idk if we got the medicine or it's coincidence"

Parent 2 on open label trial after noticing no change during blinded trial:
"Since XXX has been receiving her trial mediciation we have notived some changes..she's more engaged, her motor skills are improving and her eye contact is amazing! The best part is we are only 4 weeks in!"

Parent 3:
"Brilliant news, I was unconvinced despite promising phase 2 results and a couple of rett parents singing its praises no end.Having seen its affects first hand in some of the girls in the phase 3 trial it can't come quick enough so anything that can give it that helping hand through the red tape is most welcomed""improved motor function, things children haven't done in years, bear weight, steps, hand to mouth feeding. Word in a couple of cases. We aren't talking a cure but some good smaller improvements that can help their qol."

https://hotcopper.com.au/threads/5854948/#post-50371245
Fair bet researchers and Acadia would have access to a lot more insight than everyone else.

Expand

Alright I’ve sourced your quotes so will follow along. Thanks for posting

NEU Price at posting: $1.43 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BUX

Buxton projects new graphite province discovery at WA Narryer play

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 24 more messages in this thread...

First 22 Last

Add NEU (ASX) to my watchlist

(20min delay)
Last $14.05		Change -0.510(3.50%)		Mkt cap ! $1.795B

Open	High	Low	Value	Volume
$14.38	$14.42	$13.94	$6.419M	454.6K

Buyers (Bids)

No.	Vol.	Price($)
1	500	$13.99

Sellers (Offers)

Price($)	Vol.	No.
$14.07	6644	4

View Market Depth

No.	Vol.	Price($)
1	500	13.990
1	300	13.970
1	1432	13.950
2	1230	13.900
1	720	13.890

Price($)	Vol.	No.
14.420	175	1
14.500	2985	2
14.800	2850	2
14.860	500	1
14.960	445	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)

NEU (ASX) Chart

China deal?, page-22

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

China deal?, page-22

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News